4//SEC Filing
Masi Dina 4
Accession 0001345281-25-000002
CIK 0001016504other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:41 PM ET
Size
7.4 KB
Accession
0001345281-25-000002
Insider Transaction Report
Form 4
Masi Dina
Chief Financial Officer
Transactions
- Award
Common Stock
2025-05-21$0.09/sh+135,000$12,150→ 347,200 total - Disposition to Issuer
Stock Option (right to buy)
2025-05-21−135,000→ 0 totalExercise: $0.09Exp: 2025-06-02→ Common Stock (135,000 underlying)
Footnotes (2)
- [F1]135,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
- [F2]72,500 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001345281
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:41 PM ET
- Size
- 7.4 KB